Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02721082 · ClinicalTrials.gov registry record · Phase 4
Changing the Default for Tobacco Treatment
A Phase 4 study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,000
- Enrollment target
NCT02721082 is a Phase 4 study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 1,000 participants.
The verdict
NCT02721082, a Phase 4 study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,000 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the impact and efficacy of a new approach to smoking cessation treatment versus the traditional approach.
Interventions
- DRUG Nicotine Replacement Therapy
- BEHAVIORAL Opt Out Treatment Program
- BEHAVIORAL Opt In Treatment Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2020-12-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02721082
The ClinicalTrials.gov registry entry for NCT02721082 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nicotine Replacement Therapy is the first listed.
NCT02721082 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02721082 about?
NCT02721082 is a clinical study titled "Changing the Default for Tobacco Treatment". The purpose of this study is to determine the impact and efficacy of a new approach to smoking cessation treatment versus the traditional approach.
What is the current status of trial NCT02721082?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,000 participants. The study started on 2016-09-01. Estimated completion is 2020-12-09.
What interventions are being tested in trial NCT02721082?
The interventions under investigation include: Nicotine Replacement Therapy (DRUG), Opt Out Treatment Program (BEHAVIORAL), Opt In Treatment Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02721082?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.